Guided Capital Wealth Management LLC Takes Position in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Guided Capital Wealth Management LLC acquired a new position in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) in the first quarter, according to its most recent disclosure with the SEC. The firm acquired 43,953 shares of the company's stock, valued at approximately $1,794,000. Establishment Labs accounts for about 1.5% of Guided Capital Wealth Management LLC's portfolio, making the stock its 22nd biggest position. Guided Capital Wealth Management LLC owned about 0.15% of Establishment Labs as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently modified their holdings of ESTA. Handelsbanken Fonder AB boosted its holdings in shares of Establishment Labs by 32.3% in the fourth quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company's stock valued at $378,000 after acquiring an additional 2,000 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in Establishment Labs in the fourth quarter valued at about $5,494,000. Black Swift Group LLC boosted its holdings in Establishment Labs by 98.6% in the 4th quarter. Black Swift Group LLC now owns 14,300 shares of the company's stock valued at $659,000 after purchasing an additional 7,100 shares in the last quarter. Swiss National Bank boosted its holdings in Establishment Labs by 2.7% in the 4th quarter. Swiss National Bank now owns 38,500 shares of the company's stock valued at $1,774,000 after purchasing an additional 1,000 shares in the last quarter. Finally, Royce & Associates LP acquired a new position in Establishment Labs during the 4th quarter worth approximately $4,862,000. 72.91% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

ESTA has been the subject of several recent analyst reports. BTIG Research began coverage on Establishment Labs in a report on Friday, May 16th. They issued a "buy" rating and a $62.00 price target for the company. Needham & Company LLC reiterated a "buy" rating and issued a $48.00 price objective on shares of Establishment Labs in a research report on Friday, June 13th. Wall Street Zen upgraded shares of Establishment Labs from a "sell" rating to a "hold" rating in a research report on Saturday, June 14th. Finally, Stephens reaffirmed an "overweight" rating and set a $52.00 price target on shares of Establishment Labs in a research note on Thursday, March 6th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $52.40.

Establishment Labs Price Performance

NASDAQ ESTA traded down $0.08 during mid-day trading on Friday, hitting $37.95. The stock had a trading volume of 62,405 shares, compared to its average volume of 472,816. The company has a 50 day simple moving average of $34.51 and a 200 day simple moving average of $37.14. The company has a market cap of $1.10 billion, a price-to-earnings ratio of -12.26 and a beta of 0.74. Establishment Labs Holdings Inc. has a 52-week low of $26.56 and a 52-week high of $52.41. The company has a quick ratio of 2.05, a current ratio of 3.36 and a debt-to-equity ratio of 5.72.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported ($0.70) earnings per share for the quarter, beating analysts' consensus estimates of ($0.83) by $0.13. Establishment Labs had a negative return on equity of 196.25% and a negative net margin of 52.34%. The business had revenue of $41.38 million during the quarter, compared to analysts' expectations of $41.15 million. During the same quarter last year, the business posted ($0.58) earnings per share. The business's revenue for the quarter was up 11.3% on a year-over-year basis. Equities analysts forecast that Establishment Labs Holdings Inc. will post -2.41 EPS for the current fiscal year.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.